U.S. flag

An official website of the United States government

Filters

reset all

Other countries

Results: 1 to 20 of 30

Tests names and labsConditionsGenes, analytes, and microbesMethods

Cancer Hotspot Panel

Genome-Nilou Lab
Iran
4534
  • E Sequence analysis of select exons

Leukemia, acute myeloid, somatic, 601626 (Acute myeloid leukemia with recurrent genetic anomaly) V617F Mutation and (Exon 12-14) (JAK2 gene) (Dizi Analizi) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Leukemia, acute myeloid, somatic, 601626 (Unclassified acute myeloid leukemia) (FLT3 gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Leukemia, acute myeloid, reduced survival in, somatic, 601626 (Unclassified acute myeloid leukemia) (FLT3 gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Comprehensive HemeComplete Profile with IGH Somatic Hypermutation

PathGroup
United States
13161
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Comprehensive Panel for Individualized Cancer Threatment

GeneKor MSA
Greece
1652
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • E Sequence analysis of select exons
  • T Targeted variant analysis

GIST, Acute myeloid leukemia , Mast cell leukemia , Melanoma (sequence analysis of 8, 9, 10, 11, 13, 17 and 18 exons of KIT gene)

CGC Genetics Unilabs
Portugal
51
  • E Sequence analysis of select exons

Myeloproliferative / myelodysplastic syndrome [detection of somatic mutations: JAK2 (V617F and exon 12), CALR (exon 9) , MPL (exon 10), ASXL1 (exon 13), CBL (exons 8 and 9), CSF3R (exons 14 – 17), DNMT3A (whole coding region), ETNK1 (exon 3), EZH2 (whole

CGC Genetics Unilabs
Portugal
315
  • E Sequence analysis of select exons

Mast Cell Leukemia , Acute myeloid leukemia (search of p.D816V mutation of KIT gene)

CGC Genetics Unilabs
Portugal
21
  • E Sequence analysis of select exons

FLT3 TKD Mutation

Molecular Diagnostic Laboratory Nebraska Medicine
United States
11
  • E Sequence analysis of select exons

Myeloid Neoplasm Sequencing Panel V2.0

Tulane Hayward Genetics Center Molecular Diagnostics Lab Tulane University
United States
41
  • E Sequence analysis of select exons

JAK2 Exon 12 Mutations

Duzen Laboratories Duzen BBAGUAS
Turkey
41
  • E Sequence analysis of select exons

IDH2 exon 4 analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
31
  • E Sequence analysis of select exons

IDH1 exon 4 analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
31
  • E Sequence analysis of select exons

GATA1 exon2 analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
21
  • E Sequence analysis of select exons

CEBPA Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM)

Baylor Genetics
United States
11
  • E Sequence analysis of select exons

KIT Mutations in AML by Fragment Analysis and Sequencing

ARUP Laboratories, Molecular Oncology ARUP Laboratories
United States
11
  • E Sequence analysis of select exons
  • T Targeted variant analysis

CEBPA Sequence Analysis (Prenatal Sequence Analysis)

Baylor Genetics
United States
11
  • E Sequence analysis of select exons

NeoTYPE® AML Prognostic Profile

NeoGenomics Laboratories NeoGenomics Laboratories, Inc.
United States
128
  • E Sequence analysis of select exons

IDH1/IDH2 Mutation Analysis by PCR

NeoGenomics Laboratories NeoGenomics Laboratories, Inc.
United States
22
  • E Sequence analysis of select exons

Results: 1 to 20 of 30

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.